BML Investment Partners, L.P. 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-22 4:24 pm Purchase | 2024-07-17 | 13G | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 2,206,346 10.600% | 1,065,346 (+93.37%) | Filing |
| 2024-04-29 4:10 pm Purchase | 2024-04-18 | 13G | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 1,141,000 5.500% | 655,575 (+135.05%) | Filing |
| 2024-02-07 11:36 am Sale | 2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 485,425 2.300% | -244,593 (-33.51%) | Filing |
| 2023-02-08 4:44 pm Purchase | 2023-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 730,018 7.300% | 212,468 (+41.05%) | Filing |
| 2022-05-10 12:40 pm Purchase | 2022-05-04 | 13G | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 517,550 5.200% | 517,550 (New Position) | Filing |